Yer right , as though you have no idea of the company or the trial that I was referring too despite holding shares in it . CYP cohort B shows a clinicl response at 3 days .
Now as I asked you yesterday and the day before.
You have a child that has a bad blood test. Data suggest about a 20% chance of survival . Decision is made for Remestemcell-L to be administered as the product has been deemed safe and the child has more than 3 times the chance of long term survival . I should see a response within 3 days and blood test will confirm that response at 7 days , that will confirm that my patient is very likely to survive long term. Would you not think to take action ,report and demand another batch of Remestemcell-L if a response was inadequate?
Now we may not agree that MSCs provide rapid response or that our therapy even works., it should not be a concern to the FDA as the Dr would be concerned if he had not observed a clinical response at day 3 and a blood test would be taken at day 7 to confirm ether a negative or a positive outcome.
The reasons for the FDA concern over potency assays have gone from been significant at time of the ODAC meeting to now a fairly minimal concern.
DO YOU AGREE?
- Forums
- ASX - By Stock
- MSB
- banter and General Discussion
banter and General Discussion, page-4718
-
- There are more pages in this discussion • 5,892 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 96.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 86854 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16000 | 0.965 |
1 | 23000 | 0.960 |
8 | 163220 | 0.955 |
8 | 87646 | 0.950 |
3 | 82684 | 0.945 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 86854 | 7 |
0.975 | 37184 | 2 |
0.980 | 44810 | 6 |
0.985 | 88504 | 4 |
0.990 | 54328 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online